Clarissa Willett | VP, IR |
David King | Chairman, CEO & President |
Glenn Eisenberg | CFO & EVP |
John Ratliff | CEO, Covance Drug Development |
Jack Meehan | Barclays Bank |
Suzie Yoon | Evercore ISI |
Lisa Gill | JPMorgan Chase & Co. |
Eric Coldwell | Robert W. Baird & Co. |
Kevin Ellich | Craig-Hallum |
Rivka Goldwasser | Morgan Stanley |
Daniel Leonard | Deutsche Bank |
Erin Wright | Crédit Suisse |
Patrick Donnelly | Goldman Sachs Group |
Ralph Giacobbe | Citigroup |
Kevin Caliendo | UBS Investment Bank |
Bryan Ross | Jefferies |
Matthew Larew | William Blair & Company |
Mark Massaro | Canaccord Genuity |
Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Q2 2019 LabCorp Earnings Conference Call. [Operator Instructions].
As a reminder, this conference call is being recorded for replay purposes. It is now my pleasure to hand the conference over to, Ms.